Skip to main content
Premium Trial:

Request an Annual Quote

imaGenes Joins ORFeome Collaboration

NEW YORK (GenomeWeb News) – Berlin, Germany-based imaGenes has joined the international ORFeome Collaboration, an effort spearheaded by the NIH’s National Human Genome Research Institute.
The goal of the ORFeome collaboration is to provide the research community with an unrestricted source of fully validated human and mouse cDNA clones covering the entire protein-coding sequence of the respective genes. The clones allow for the production of native or modified human proteins for functional analyses or for therapeutic applications.
imaGenes said that it will contribute proprietary clones and will provide high-quality sequencing of 2,000 single clones out of poorly characterized clone pools.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.